Company patents
GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Global Life Sciences Solutions USA LLC's patent strategy is heavily concentrated in Bioreactors / Cell Culture Apparatus, which accounts for 74.6% of its portfolio, yet this core area has seen a significant decline of 60.7% in patent filings so far in 2026. Surprisingly, despite its name, the company has shown a shifting priority away from Drug Delivery Devices, with a 100% decline in filings in both 2024 and so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
130 US filings (since 2023) · 12 categories · 14 themes
Systems and components designed for mixing fluids in biological or pharmaceutical processes, often involving cell cultures, RNA synthesis, or nanoparticle formation, with considerations for sterility, automation, and precise control.
Innovations in the physical design and modularity of bioreactor vessels and associated components, focusing on improved handling, scalability, perfusion, or integration within larger systems.
Systems and methods for automated monitoring and dynamic adjustment of environmental parameters (e.g., pH, temperature, oxygen, nutrients) and fluid handling within bioreactors to optimize cell/tissue growth or product synthesis.
Methods and apparatus specifically tailored for the expansion, differentiation, or genetic modification of cells for therapeutic applications (e.g., CAR T cells, progenitor cells) or for the production of specific biological products (e.g., cultured fat, RNA).
Membrane and depth filtration for industrial separation, gas purification, and bioprocess clarification including cross-flow, dead-end, tangential flow filtration, and oil/water separation.
Devices and systems designed for the cultivation of cells or tissues, often incorporating three-dimensional structures or controlled interfaces to mimic in-vivo environments for biological research or production.
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Techniques and apparatus for cultivating cells in three-dimensional structures, including organoids, tissue models, and scaffolds, often involving microfluidics, specialized matrices, or mechanical stimulation to mimic in vivo conditions.
Mixing apparatus designed for integration directly into a fluid conduit or a continuous process stream, often employing static elements, impellers within a flow path, or multi-component injection for efficient, uninterrupted processing.
Methods and reagents designed to improve the specificity, efficiency, or yield of nucleic acid capture, ligation, amplification, or library preparation steps, particularly for sequencing applications or quantitative analysis.
Development of novel materials, surface patterns, or structural supports designed to enhance cell adhesion, proliferation, differentiation, or tissue formation, including hydrogels and patterned surfaces.
Assays leveraging CRISPR-Cas systems (e.g., Cas12, Cas13) for highly specific and sensitive detection of target nucleic acids, often involving collateral cleavage activity or reporter molecules.
Devices and methods that utilize high-speed mechanical action, fluid impact, or cavitation phenomena to intensely mix, disperse, or treat fluids, often for emulsification, particle size reduction, or decontamination.
Innovations in the design, materials, and manufacturing of lithography masks, including reflective masks, programmable masks, and defect mitigation strategies, to enable finer feature patterning and process control.
Patents
Showing 1-10 of 227